AGTC Presents Data from Ongoing Phase 1/2 Trial of AGTC-501 …
https://agtc.gcs-web.com/news-releases/news-release-details/agtc-presents-data-ongoing-phase-12-trial-agtc-501-upcoming
WebNov 12, 2021 · GAINESVILLE, Fla. and CAMBRIDGE, Mass., Nov. 12, 2021 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), a biotechnology company conducting human clinical trials of adeno-associated virus (AAV)-based gene therapies for the treatment of rare inherited retinal diseases (IRDs), today …
DA: 77 PA: 24 MOZ Rank: 40